Skip to content

    Anxiety & Panic Disorders Health Center

    Font Size

    Medication for Anxiety Helps Older Adults

    Study Shows Lexapro Has Modest Benefits for Patients With Generalized Anxiety Disorder
    WebMD Health News
    Reviewed by Louise Chang, MD

    Jan. 20, 2009 -- Medication for anxiety is "modestly beneficial" for very anxious older adults, according to a new study, but it takes four weeks or so to work.

    Researchers looked at one specific drug, Lexapro, part of a class known as selective serotonin reuptake inhibitors (SSRIs), to see if it could help relieve the symptoms of generalized anxiety disorder (GAD) in older adults. Those with the condition worry chronically and can't seem to stop, with their quality of life affected.

    SSRIs are medications prescribed for both anxiety and depression and are thought to work by correcting an imbalance of the brain chemical serotonin.

    "Although these medications have been examined in younger adults, there has been very little examination of them in older adults," says study researcher Eric J. Lenze, MD, associate professor of psychiatry at Washington University in St. Louis.

    And the need is great, he says, with nearly one in 10 older adults affected by GAD.

    Medication for Anxiety: Study Results

    Lenze and his colleagues assigned 85 adults with GAD (average age 71) to take Lexapro. Ninety-two adults with the condition (average age 72) were assigned to take placebo pills. The participants did not know what they were taking. The study lasted 12 weeks.

    Lenze's team measured the participants' anxiety and other factors, such as social functioning and limitations in activity due to anxiety.

    At the end of 12 weeks, 69% of those in the medication group had a response, compared to 51% in the placebo group, a difference that is considered significant. Those on Lexapro had more improvement in anxiety symptoms and their self-reported functioning, the researchers found.

    But when the researchers considered the participants who dropped out, a more conservative way to analyze the findings, they found that the response rate was 57% for those who got the medicine and 45% for those on placebo -- not a significant difference.

    "A short conclusion is that the drug was modestly beneficial, and even those modest benefits can only be seen if someone sticks with the medication long enough to see if it will help or not," Lenze says.

    Today on WebMD

    young leukemia patient
    Unhappy couple
    embarrassed woman
    Phobias frightened eyes
    stressed boy in classroom
    Distressed teen girl in dramatic lighting
    man hiding with phone
    chain watch